Ken Walder

9.8k total citations · 2 hit papers
204 papers, 6.7k citations indexed

About

Ken Walder is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Ken Walder has authored 204 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 54 papers in Physiology and 36 papers in Epidemiology. Recurrent topics in Ken Walder's work include Tryptophan and brain disorders (34 papers), Adipose Tissue and Metabolism (33 papers) and Regulation of Appetite and Obesity (24 papers). Ken Walder is often cited by papers focused on Tryptophan and brain disorders (34 papers), Adipose Tissue and Metabolism (33 papers) and Regulation of Appetite and Obesity (24 papers). Ken Walder collaborates with scholars based in Australia, United States and Canada. Ken Walder's co-authors include Michael Berk, Gerwyn Morris, Michaël Maes, Greg R. Collier, Paul Zimmet, Jeremy B. M. Jowett, David Segal, Kiymet Bozaoglu, Janine McMillan and Kristy A. Bolton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Ken Walder

200 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome

2007 715 citations Greg R. Collier, Ken Walder et al. profile →
Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis

2023 113 citations Zoe Liu, Ken Walder et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Walder Australia	41	1.9k	1.8k	1.4k	972	688	204	6.7k
Karl‐Heinz Herzig Finland	51	2.0k 1.0×	1.9k 1.1×	970 0.7×	990 1.0×	246 0.4×	305	8.4k
Helle Brüünsgaard Denmark	47	1.6k 0.8×	3.1k 1.7×	1.8k 1.3×	415 0.4×	449 0.7×	117	9.5k
Amanda J. Kiliaan Netherlands	44	1.5k 0.8×	2.9k 1.6×	930 0.7×	1.0k 1.0×	660 1.0×	147	7.4k
Bruno Fève France	44	2.3k 1.2×	2.5k 1.4×	1.9k 1.3×	391 0.4×	286 0.4×	178	7.4k
Mónica De la Fuente Spain	50	2.0k 1.0×	2.0k 1.1×	707 0.5×	952 1.0×	1.2k 1.8×	276	8.5k
Takeo Yoshikawa Japan	59	5.0k 2.6×	1.1k 0.6×	622 0.4×	557 0.6×	786 1.1×	353	11.1k
Aldo E. Calogero Italy	60	2.4k 1.2×	836 0.5×	526 0.4×	506 0.5×	421 0.6×	502	13.5k
Luis Ulloa United States	48	5.8k 3.0×	1.2k 0.7×	1.2k 0.9×	425 0.4×	421 0.6×	142	13.8k
Charalabos Pothoulakis United States	78	6.2k 3.2×	2.2k 1.3×	3.7k 2.7×	1.1k 1.1×	371 0.5×	261	18.9k
Carina Mallard Sweden	65	3.2k 1.7×	867 0.5×	1.8k 1.3×	614 0.6×	539 0.8×	248	14.9k

Countries citing papers authored by Ken Walder

Since Specialization

Citations

This map shows the geographic impact of Ken Walder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Walder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Walder more than expected).

Fields of papers citing papers by Ken Walder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Walder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Walder. The network helps show where Ken Walder may publish in the future.

Co-authorship network of co-authors of Ken Walder

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Walder. A scholar is included among the top collaborators of Ken Walder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Walder. Ken Walder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berk, Michael, Ken Walder, & Jee Hyun Kim. (2025). Past, present and future of research on brain energy metabolism in bipolar disorder. World Psychiatry. 24(1). 47–49.

Machado, Alencar Kolinski, Angela Duong, Hyunjin Jeong, et al.. (2025). iPSC-derived cerebral organoids reveal mitochondrial, inflammatory and neuronal vulnerabilities in bipolar disorder. Translational Psychiatry. 15(1). 315–315. 1 indexed citations

Connor, Timothy, Javier Botella, Amanda J. Genders, et al.. (2024). Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity. Nature Communications. 15(1). 258–258. 5 indexed citations

Liu, Zoe, Bruna Panizzutti, Jee Hyun Kim, et al.. (2024). Network-based drug repurposing for schizophrenia. Neuropsychopharmacology. 49(6). 983–992. 9 indexed citations

Panizzutti, Bruna, Chiara C. Bortolasci, Briana Spolding, et al.. (2023). Effects of antipsychotic drugs on energy metabolism. European Archives of Psychiatry and Clinical Neuroscience. 274(5). 1125–1135. 3 indexed citations

Panizzutti, Bruna, David Skvarc, Chiara C. Bortolasci, et al.. (2023). Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 24(6). 5250–5250. 38 indexed citations

Nay, Kévin, Christopher R. Horne, Douglas G. Whyte, et al.. (2023). CaMKK2 as an emerging treatment target for bipolar disorder. Molecular Psychiatry. 28(11). 4500–4511. 9 indexed citations

Martin, Sheree D., Timothy Connor, Andrew Sanigorski, et al.. (2023). Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity. Cell Death and Disease. 14(12). 787–787. 7 indexed citations

Bortolasci, Chiara C., Srisaiyini Kidnapillai, Briana Spolding, et al.. (2022). Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs. International Journal of Molecular Sciences. 23(14). 7508–7508. 3 indexed citations

10.

Panizzutti, Bruna, et al.. (2022). Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders. Pharmaceutics. 14(7). 1464–1464. 13 indexed citations

11.

Panizzutti, Bruna, Chiara C. Bortolasci, Briana Spolding, et al.. (2021). Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia. International Journal of Molecular Sciences. 22(13). 7164–7164. 21 indexed citations

12.

Bortolasci, Chiara C., Briana Spolding, Srisaiyini Kidnapillai, et al.. (2020). Transcriptional Effects of Psychoactive Drugs on Genes Involved in Neurogenesis. International Journal of Molecular Sciences. 21(21). 8333–8333. 10 indexed citations

13.

Bortolasci, Chiara C., Briana Spolding, Srisaiyini Kidnapillai, et al.. (2020). Effects of psychoactive drugs on cellular bioenergetic pathways. The World Journal of Biological Psychiatry. 22(2). 79–93. 9 indexed citations

14.

Hasebe, Kyoko, Leni R. Rivera, Craig M. Smith, et al.. (2019). Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline. Brain Behavior and Immunity. 82. 309–318. 12 indexed citations

15.

Connor, Timothy, Kylie Venardos, Darren C. Henstridge, et al.. (2017). Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice. Diabetes Obesity and Metabolism. 19(7). 936–943. 17 indexed citations

16.

Morris, Gerwyn, Michael Berk, Ken Walder, & Michaël Maes. (2015). The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability. Molecular Neurobiology. 53(4). 2550–2571. 25 indexed citations

17.

Morris, Gerwyn, Michael Berk, Ken Walder, & Michaël Maes. (2015). Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Medicine. 13(1). 28–28. 134 indexed citations

18.

Simpson, Richard W, Geoffrey C. Nicholson, Joseph Proietto, et al.. (2014). Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study. Diabetes Care. 37(11). 3121–3123. 13 indexed citations

19.

Walder, Ken, et al.. (2007). Analysing interaction effects in forests using the mark correlation function. SHILAP Revista de lepidopterología. 1 indexed citations

20.

Collier, Fiona, Claudia C. Gregorio-King, Jim Apostolopoulos, Ken Walder, & Mark A. Kirkland. (2003). ORP3 Splice Variants and Their Expression in Human Tissues and Hematopoietic Cells. DNA and Cell Biology. 22(1). 1–9. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact